
Substance Use Disorder
Latest News

Advertisement
Latest Videos
Podcasts
CME Content
Advertisement
More News

GLP-1 drugs like semaglutide may curb alcohol and opioid cravings, as trials expand, combos emerge, and interaction risks surface.

Explore how neuromelanin-sensitive MRI noninvasively tracks long-term dopamine and noradrenaline system changes.

ASAM’s new youth SUD criteria help clinicians deliver developmentally tailored, prevention-first care with coordinated family and community supports.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
2
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
3
Centanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD
4
FAQ: What Clinicians Need to Know About Postpartum Psychosis
5












